CureVac N.V. (5CV.F)
EUR 2.72
(-2.01%)
EUR 2.72
(-2.01%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -1.18 EUR | 12.88% |
| 2022 | -1.32 EUR | 40.27% |
| 2021 | -2.21 EUR | -125.51% |
| 2020 | -0.98 EUR | -84.91% |
| 2019 | -0.53 EUR | -32.5% |
| 2018 | -0.40 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.33 EUR | -3.23% |
| 2024 Q1 | -0.31 EUR | 18.42% |
| 2023 Q2 | -0.30 EUR | -11.11% |
| 2023 FY | - EUR | 12.88% |
| 2023 Q1 | -0.27 EUR | 59.09% |
| 2023 Q4 | -0.38 EUR | -72.73% |
| 2023 Q3 | -0.22 EUR | 26.67% |
| 2022 Q3 | -0.26 EUR | 16.13% |
| 2022 Q2 | -0.31 EUR | -278.05% |
| 2022 Q1 | -0.08 EUR | -666.36% |
| 2022 FY | - EUR | 40.27% |
| 2022 Q4 | -0.66 EUR | -153.85% |
| 2021 Q1 | -0.62 EUR | -93.75% |
| 2021 Q3 | -0.80 EUR | 4.76% |
| 2021 Q2 | -0.84 EUR | -35.48% |
| 2021 FY | - EUR | -125.51% |
| 2021 Q4 | -0.01 EUR | 98.66% |
| 2020 Q4 | -0.32 EUR | -60.0% |
| 2020 Q3 | -0.20 EUR | -241.88% |
| 2020 Q2 | -0.06 EUR | 58.21% |
| 2020 Q1 | -0.14 EUR | 30.0% |
| 2020 FY | - EUR | -84.91% |
| 2019 Q1 | -0.12 EUR | 0.0% |
| 2019 Q3 | -0.10 EUR | 0.0% |
| 2019 FY | - EUR | -32.5% |
| 2019 Q4 | -0.20 EUR | -100.0% |
| 2018 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| BioNTech SE | 3.87 EUR | 130.491% |
| Biotest Aktiengesellschaft | 3.21 EUR | 136.76% |
| Biotest Aktiengesellschaft | 3.21 EUR | 136.76% |
| BRAIN Biotech AG | -0.38 EUR | -210.526% |
| Formycon AG | 4.76 EUR | 124.79% |
| Heidelberg Pharma AG | -0.44 EUR | -168.182% |
| Medigene AG | -0.66 EUR | -78.788% |